XML 128 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Tables)
 12 Months Ended
Dec. 31, 2022
Disclosure of equity [abstract]  
Schedule disclosing information related to movement in the share capital

(USD millions)

Jan 1, 2020
Movement
in year

Dec 31, 2020
Movement
in year

Dec 31, 2021
Movement
in year

Dec 31, 2022
Share capital 1
936
-23
913
-12
901
-11
890
Treasury shares
-80
27
-53
5
-48
-44
-92
Outstanding share capital
856
4
860
-7
853
-55
798
 1  The Novartis AG share capital consists of registered shares with a nominal value of CHF 0.50 each. No authorized and conditional capital exists.
Schedule disclosing information related to movement in the shares
2022
2021
2020

Number of outstanding shares
(in millions)


Note
Total
Novartis
shares
Total
treasury
shares1
Total
outstanding
shares
Total
Novartis
shares
Total
treasury
shares1
Total
outstanding
shares
Total
Novartis
shares
Total
treasury
shares1
Total
outstanding
shares
Balance at beginning of year
2 434.4
-199.5
2 234.9
2 467.0
-210.2
2 256.8
2 527.3
-262.3
2 265.0
Shares canceled for capital reduction  2
-30.7
30.7
-32.6
32.6
-60.3
60.3
Shares acquired to be canceled  3
-126.2
-126.2
-30.7
-30.7
-32.6
-32.6
Other share purchases 4
-1.4
-1.4
-1.5
-1.5
-1.7
-1.7
Exercise of options and employee transactions  5
18.9
1.9
1.9
0.6
0.6
14.7
14.7
Equity-based compensation 5
10.4
10.4
9.6
9.6
11.0
11.0
Shares delivered to Alcon employees
0.0
0.0
0.1
0.1
0.4
0.4
Total movements
-30.7
-84.6
-115.3
-32.6
10.7
-21.9
-60.3
52.1
-8.2
Balance at end of year
2 403.7
-284.1
2 119.6
2 434.4
-199.5
2 234.9
2 467.0
-210.2
2 256.8
 1  Approximately 99.0 million treasury shares (2021: 102.5 million; 2020: 103.0 million) are held in Novartis entities that restrict their availability for use.
 2  Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years.
 3  Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2019 Annual General Meeting (AGM) for transactions after February 28, 2019, until March 2, 2021. Transactions after March 2, 2021, were executed under the CHF 10 billion share buyback authority approved at the 2021 AGM and the additional CHF 10 billion authority approved at the 2022 AGM.
 4  Shares acquired from employees, which were previously granted to them under the respective equity-based participation plans
 5  Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans
    
Schedule disclosing information related to Dividend
2022
2021
2020
Dividend per share (in CHF)
3.10
3.00
2.95
Total dividend payment (in USD billion)
7.5
7.4
7.0
Schedule disclosing information related treasury shares movements
2022
2021
2020



Note
Number of
outstanding
shares
(in millions)


Equity impact
USD m
Number of
outstanding
shares
(in millions)


Equity impact
USD m
Number of
outstanding
shares
(in millions)


Equity impact
USD m
Shares acquired to be canceled 1
-126.2
-10 787
-30.7
-2 775
-32.6
-2 897
Other share purchases 2
-1.4
-123
-1.5
-145
-1.7
-159
Purchase of treasury shares
-127.6
-10 910
-32.2
-2 920
-34.3
-3 056
Exercise of options and employee transactions 3
18.9
1.9
88
0.6
39
14.7
806
Equity-based compensation 4
10.4
854
9.6
745
11.0
730
Shares delivered to Alcon employees
0.0
5
0.1
17
0.4
30
Total
-115.3
-9 963
-21.9
-2 119
-8.2
-1 490
 1  Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2019 Annual General Meeting (AGM) for transactions after February 28, 2019, until March 2, 2021. Transactions after March 2, 2021, were executed under the CHF 10 billion share buyback authority approved at the 2021 AGM and the additional CHF 10 billion authority approved at the 2022 AGM.
 2  Shares acquired from employees, which were previously granted to them under the respective equity-based participation plans
 3  Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised.
 4  Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity.